Skip to content

To study the effect of conventional medicines in liver disorders with blood purifiers as mentioned in Ayurveda

A randomized comparative trial with Rakta Prasadak Ausadha in Yakrita Dushti for validation of Garbhasya yakratpleehano shonitajo - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077204
Enrollment
60
Registered
2024-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with already known case of any liver disorders (pre-hepatic and hepatic cause) with deranged LFT (liver function test) values falling in the range. 2. Patient of either sex having age between of 18 to 50 yrs. 3. Patients who are willing to sign consent form for the trial

Exclusion criteria

Exclusion criteria: i. Patients below age of 18 yrs and above 50 yrs. ii.Patient with k/c/o uncontrolled Diabetes, Hypertension, Carcinoma, etc. iii. Patients with post hepatic conditions such as common bile duct obstruction, liver cirrhosis, bile duct tumor, carcinoma of pancreas head, etc. iv. Patient participated in any clinical trial with in last six months. V. Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
CLASSICAL SIGN AND SYMPTOMS OF YAKRITA DUSHTI AS PER SAMHITATimepoint: after 4week

Secondary

MeasureTime frame
Based upon the changes in liver function test, CBC, TECTimepoint: 15 days

Countries

India

Contacts

Public ContactDr. Neha Udainiya

National Institute of Ayurveda

neha.rs@nia.edu.in8607429931

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026